International Biotechnology Trust’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

International Biotechnology Trust’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,600	Closed	-$564K	–	81
2021 Q3	$564K	Sell	16,600 -83,400	-83%	-$2.66M	0.14%	57
2021 Q2	$3.66M	Hold	100,000	–	–	0.97%	27
2021 Q1	$4.48M	Buy	100,000 +50,000	+100%	+$2.33M	1.19%	22
2020 Q4	$2.85M	Buy	50,000 +33,000	+194%	+$1.96M	0.78%	27
2020 Q3	$872K	Hold	17,000	–	–	0.28%	45
2020 Q2	$994K	Hold	17,000	–	–	0.33%	42
2020 Q1	$697K	Hold	17,000	–	–	0.32%	44
2019 Q4	$1.06M	Hold	17,000	–	–	0.38%	47
2019 Q3	$577K	Buy	+17,000	New	+$503K	0.27%	49
2018 Q4	–	Sell	-77,000	Closed	-$2.29M	–	52
2018 Q3	$2.29M	Hold	77,000	–	–	1.09%	29
2018 Q2	$3.03M	Hold	77,000	–	–	1.16%	30
2018 Q1	$1.54M	Hold	77,000	–	–	0.6%	37
2017 Q4	$1.75M	Buy	77,000 +52,000	+208%	+$1.02M	0.62%	40
2017 Q3	$478K	Buy	+25,000	New	+$458K	0.19%	53

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

International Biotechnology Trust's DCPH Position: Q4 2021 in Review

International Biotechnology Trust sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 16,600 shares — an estimated $564K sold.

International Biotechnology Trust first reported a position in DCPH in Q3 2017 and held it in 14 quarters. The position peaked at $4.48M in Q1 2021. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

International Biotechnology Trust reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
International Biotechnology Trust sold 16,600 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $564K.
International Biotechnology Trust first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 14 quarters.
International Biotechnology Trust's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $4.48M in Q1 2021.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on International Biotechnology Trust's 13F filing for Q4 2021, filed 15 Feb 2022.